GSK will discontinue camlipixant’s late-stage RCC programme, though it will continue the drug’s development in two forms of IBS.

There are several evidence-based lifestyle and diet changes you can make right now to support your gut. For example, eating ...

GlobalFY26 sales AUD$7.7 million up 6% on prior comparative period (pcp)2H FY26 sales AUD$3.5 million up 7% on pcp4Q FY26 sales AUD$2.0 million up 2% on pcpAustraliaFY26 sales AUD$5.8 million up 10% ...

Lufthansa Cargo has collaborated with WiseTech Global and IBS Software to implement the International Air Transport ...

Having diarrhea is already a miserable experience, but it might be even worse if it’s caused by the parasite cyclospora, ...

Even if you suffer from Irritable Bowel Syndrome, these anal health experts will have you bottoming again in no time.

Irritable bowel syndrome, commonly called IBS, is one of the most common digestive disorders. Millions of people live with ...

Director Kim V. Narry First Korean to Win Nakasone Award Renowned RNA biologist recognized for mRNA tail discoveries; calls ...

A meta-analysis of sham-controlled clinical trials has found that acupuncture significantly improves symptoms of irritable ...

Everyone now has access to the same AI models, but IBS Software believes deep industry expertise will be the real competitive ...

IBS Group has launched Naviq Technology, an AI-focused company for the global travel industry. The new venture will be ...

Scientists have made an important discovery that could change the way doctors understand irritable bowel syndrome (IBS), a ...